$9.03-0.36 (-3.83%)
Buda Juice, Inc.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $3.51M↑ | $2.90M | — | $2.98M↑ | $2.77M |
| Gross Profit | $1.39M↑ | $1.22M | — | $1.34M↑ | $1.25M |
| Operating Income | $593,000↑ | $591,000 | — | $803,000↑ | $802,000 |
| Net Income | $388,000↓ | $675,000 | — | $807,000↓ | $965,000 |
Buda Juice, Inc. engages in producing and distributing juice, lemonades, limeades, and wellness shots in the United States. The company offers clean-label beverages; citrus juices; and cold-pressed juices made from fruits and vegetables. The company ...
Grow Funds, an investment Advisor, released its Q1 2026 investor letter for “GROW Small Cap Equity Long/Short Fund”. A copy of the letter can be downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index’s –2.80%, HFRI Equity Hedge Index’s -0.24%, and the HFRI Fundamental […]
Buda Juice (AMEX:BUDA) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. The full earnings call is available at https://events.q4inc.com/attendee/605302226 Summary Buda Juice reported a 17.7% year-over-year revenue growth for the first quarter of 2026, driven entirely by its exis
BUDA (NYSEAMERICAN:BUDA) executives highlighted profitable growth, a debt-free balance sheet, and early momentum in 2026 during the company’s fourth-quarter and full-year 2025 earnings call—its first as a public company following an IPO completed in January. IPO milestone and “ultra-fresh” position